17+ hour, 32+ min ago   (633+ words) A humble fermented milk drunk in northern Cameroon may hold the key to greener cosmetics....

2+ week, 5+ day ago   (200+ words) Aug 24, 2026 6:57pm EDT GERMANTOWN, Md., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today provided an update regarding the anticipated closing of its proposed combination with Clywedog Therapeutics, Inc. (“Clywedog”) in an all-stock transaction. Notice of Delisting…...

3+ day, 4+ hour ago   (166+ words) About NetDragon Websoft Holdings Limited NetDragon's overseas edtech business entity, currently a U.S.-listed subsidiary named Mynd.ai, is a global leader in interactive technology and its award-winning interactive displays and software can be found in more than 2 million learning and…...

3+ day, 22+ min ago   (248+ words) CHICAGO — Protein2o, a manufacturer of fruit-flavored, clear protein water formulated with whey protein isolate, has named Mark Rappaport as chief executive officer. Rappaport succeeds Chris Pruneda. Rappaport brings more than two decades of experience in the beverage and consumer brands space,…...

3+ day, 2+ hour ago   (503+ words) The standalone entity brings 230 kL reactor capacity, 400+ scientists and specialist teams for HPAPIs, PROTACs, oligonucleotides and ADC payloads — with proximity to Shilpa Biologicals enabling integrated ADC development within a 200-mile supply chain Shilpa Medicare has announced the launch of a…...

3+ day, 7+ hour ago   (1382+ words) HEM Pharma is expanding its microbiome-centered business into products, manufacturing and AI-powered healthcare, taking a different path from Korean peers that have scaled back microbiome drug development or shifted toward other modalities. The company has expanded from gut microbiome analysis…...

3+ day, 3+ hour ago   (479+ words) Burning Rock Biotech Limited reported a 9.3% revenue decrease in Q2 2026, with significant product updates and ongoing financial challenges. For the three months ended June 30, 2026, the revenue was RMB134.7 million, a 9.3% decrease from 2025. The OncoScreen® BCMatch Tissue Kit entered the Priority Review Channel…...

3+ day, 6+ hour ago   (21+ words) Hong Kong ready to be biotech bridge, says Paul Chan gbcode.rthk.hk Hong Kong ready to be biotech bridge, says Paul Chan...

3+ day, 17+ hour ago   (124+ words) TradingView Repligen to acquire BioLife Solutions for $11.25 cash plus 0.1442 shares per BioLife share BioLife Solutions agreed to be acquired by Repligen for $11.25 cash and 0.1442 shares of Repligen stock per BioLife share. - Merger agreement: Repligen will acquire all outstanding BioLife common…...